The US president also cut funding for international groups that provide abortions, and froze hiring of some federal workers.
Trump threatens to impose additional $200 billion in tariffs on China, Beijing vows to retaliate
Google received 31,497 complaints from users and removed 94,173 pieces of content based on those complaints in December, the tech giant said in its monthly transparency report.
Addressing a session at the Future Investment Initiative 2019 here, Modi said India offers a huge investment opportunity in the infrastructure sector also as he emphasised that the country aims to be a $ 5 trillion economy in the next five years.
The rhetoric that we are fed daily needs to be measured against performance and the facts. That is not happening, points out Aakar Patel.
Recently, TPEM's first born electric concept, Avinya broke cover. The model promises a minimum range of 500 kilometres and advanced technology features, aimed at buyers in India and outside. TPEM, the newly formed entity may also consider a separate dedicated sales channel for the EVs with a distinctive corporate identity once the volumes reach a critical mass and throughput is large enough for the dealers to be profitable, said Chandra. Elaborating further on the hiring strategy he said, "We will hire from everywhere-wherever the talent of the required competency is available."
"I was the Governor of South Carolina, the best job serving the state that raised me. And then I got a phone call (after the 2016 elections," Haley, 48, said during a fireside chat organised by Indian Voices for Trump in Norristown in the battleground state of Pennsylvania on Saturday.
One reason for resistance to moonlighting is that WFH calls into question the necessity for the thick layers of middle and senior management which run most businesses, argues Devangshu Datta.
Heads of state and big-name billionaires opened the Paris climate summit with a bang on Monday.
Google received 26,087 complaints from users and removed 61,114 pieces of content based on those complaints in November, the tech giant said in its monthly transparency report.
'Both the Centre and the states cannot say that they have been taking good care of public health.'
At this year's TIME ball in New York City on Thursday, April 25, you would have run into a Coimbatore-born American scientist, looking lovely in Sabyasachi Mukherjee designer finery, who would most likely have been hanging out with Dua Lipa.
In addition to reports from users, Google also removed 3,84,509 pieces of content in October as a result of automated detection.
Modi's hopeful rhetoric has not yet turned into concrete policy reform
It is a very different victory of Maradona that fascinates me even more, notes ad guru Sandeep Goyal.
'Streaming will get to 100-200 million subscribers, but the journey is not as rose-tinted.'
Prime Minister Narendra Modi on Saturday called for following a 'one earth, one health' approach to effectively deal with the coronavirus pandemic globally, and sought the support of the G7 grouping to lift patent protections for COVID-19 vaccines, during a virtual address at an outreach session of a summit of the bloc.
While industry is upbeat, start-ups in the space sector are finding it difficult to cater to the demand due to a lack of funding, issues related to policy like foreign funding, intellectual property, etc, and a lack of support in testing.
In a blog post, Google said its Threat Analysis Group tracks more than 270 targeted or government-backed groups from over 50 countries. It, however, did not clarify which governments have targeted these users.
Taxation and intellectual property rights issue are some basic starting point impediments for US businesses in India, a top Indian-American CEO said on Monday.
The Board of Control for Cricket in India, is locked in a legal battle with the Service Tax (ST) department, which has demanded an amount of Rs 536 crore (approx) as taxes on cricket board's earnings from royalty and media rights in the last one decade.
India's Supreme Court in April rejected a patent for Novartis AG's cancer drug Glivec, saying it was an amended version of a known molecule called imatinib, setting the precedent for more such cases in the country.
A title match requires months of preparation and pulling out of other events, putting together a team of seconds, etc. Carlsen just says he lacks the motivation to do this again.
Designer of Aam Aadmi Party logo, Sunil Lal has served a legal notice to party convener and Delhi Chief Minister Arvind Kejriwal asking him to withdraw the symbol from all official works including the website failing which he would move court.
The Bill says that the central government, in consultation with the Data Protection Authority, can direct any data fiduciary or data processor to provide non-personal data to enable better targeting of delivery of services. The government can also ask data processors to provide data for formulation of evidence-based policies for its own use.
After facing multiple outages that irked the regulator, the country's largest private sector lender, HDFC Bank, is revamping its technology infrastructure by making large scale investments, wherein it is bringing new talent, getting into cloud-native stacks, a shift from the traditional monolithic IT infrastructures, and working with strategic partners for better products and services. The bank management is clear that it will do whatever it takes in line with its growth path to ramp up its technology infrastructure.
'My quest to be a meaningful participant in democracy & help shape pro-people policy led to a 10yr rollercoaster ride! As I turn the page, time to go to the Real Masters, THE PEOPLE, to better understand the issues & the path to Peoples Good Governance,' Kishor said in a tweet.
The deal covers patents currently owned by the companies, as well as any filed in the next 10 years.
This is to take head on big American pharmaceutical giants, which in the recent past had launched a strong anti-India campaign against efforts of such companies to provide affordable health care not only to people in India, but also in the third world countries.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
Ambani said, it will be ready for trials as soon as 5G spectrum is available and can be ready for field deployment next year.
India has ended regulatory uncertainty: Modi assures Malaysia.
.jpg)
Global pharmaceutical firms have had a series of patent disputes with Indian makers of generic drugs and several recent Indian rulings have gone against the international giants.
The challenge before TCS is to be totally at home with the IPR regime of developed economies.
'This is still a relatively immature defense and high-tech relationship.'
Firm attributes move to pandemic and legal spat with Fiat Chrysler, says it is in line with group's strategy to re-think capital allocation and drive efficiency.
US wants to include climate change deal in it; India disinclined
Industry leaders are predicting hybrid cloud to be the next biggest trend in cloud computing.
Decoding four important provisions in the Finance Bill 2018.
The National Institute of Virology (NIV) in Pune under the ICMR has isolated the monkeypox virus from the clinical specimen of a patient, which can pave the way for development of diagnostic kits and vaccines against the disease, officials said on Wednesday.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances